Key result
ECMO for cardiopulmonary failure faces ongoing ethical, cost, and utilization challenges.
Answers are grounded in this paper and cite their sources.
Since the first successful application of extracorporeal membrane oxygenation (ECMO) in 1972, ECMO's role in the management of respiratory and circulatory collapse continues to be refined and debated. Randomized clinical trials aimed at establishing efficacy and patient selection criteria have been fraught with ethical challenges. Growing concerns over rising health care costs require that careful evaluations of cost, utilization, and ethical issues surrounding heroic life-saving interventions such as ECMO are undertaken. Continued analyses of ECMO's place in the medical management of respiratory and circulatory failure will help ensure that ECMO is used for not only prolonging life but also for providing a chance for "quality of life" following recovery from near-fatal illnesses.
No takes yet. Share an insight, caveat, or question.
Crow et al. (2009) conducted a review in Respiratory and circulatory collapse. Extracorporeal membrane oxygenation (ECMO) was evaluated. Extracorporeal membrane oxygenation (ECMO) for respiratory and circulatory failure continues to face ethical, cost, and utilization challenges that require careful evaluation.
Synapse has enriched 10 related papers. Consider them for comparative context: